Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-196306
Filing Date
2026-04-30
Accepted
2026-04-30 14:09:05
Documents
14
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A hrtx-20260430.htm   iXBRL DEF 14A 2463328
2 GRAPHIC img125541941_0.jpg GRAPHIC 120727
3 GRAPHIC img125541941_1.jpg GRAPHIC 83353
  Complete submission text file 0001193125-26-196306.txt   4257394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20260430.xsd EX-101.SCH 13302
17 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20260430_htm.xml XML 426861
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 26923216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)